Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Disaia

Showing results (11-20 of 240) with videos related to

Pageof 24
Sort By:
Annals of the New York Academy of Sciences|January 1, 1991
Management of early adenocarcinoma of the endometrium with surgical staging followed by tailored adjuvant radiation therapyP J DiSaia
Journal of Surgical Oncology|March 1, 1997
Estrogen replacement therapy for the breast cancer survivor: a reappraisalP J Disaia
Gynecologic Oncology|July 1, 1999
Correlation between in vitro drug response in the EDR assay and response to primary paclitaxel and cisplatinP J DiSaia
The Journal of Reproductive Medicine|January 1, 1975
Immunological aspects of gynecological malignanciesP J DiSaia
The Western Journal of Medicine|February 1, 1976
Tumor immunologyP J Disaia
Gynecologic Oncology|January 1, 1997
What is the proper extent of an inguinal lymphadenectomy for early vulvar cancer?P J DiSaia
Hospital Practice (Office Ed.)|April 15, 1987
Diagnosis and management of ovarian cancerP J DiSaia
Cancer|July 15, 1981
Surgical aspects of cervical carcinomaP J DiSaia
Seminars in Surgical Oncology|September 1, 1994
Gynecological sarcomasP J DiSaia, S Pecorelli
American Journal of Clinical Oncology|February 1, 1991
Human lymphoblastoid interferon (IFN-alpha-N1) plus doxorubicin, cyclophosphamide, and cisplatin in the treatment of advanced epithelial ovarian malignancies. A phase I-II study of the Gynecologic Oncology GroupP J DiSaia, P Gillette
Pageof 24

Showing results (11-20 of 240) with videos related to

Sort By:
Pageof 24
Annals of the New York Academy of Sciences|January 1, 1991
Management of early adenocarcinoma of the endometrium with surgical staging followed by tailored adjuvant radiation therapyP J DiSaia
Journal of Surgical Oncology|March 1, 1997
Estrogen replacement therapy for the breast cancer survivor: a reappraisalP J Disaia
Gynecologic Oncology|July 1, 1999
Correlation between in vitro drug response in the EDR assay and response to primary paclitaxel and cisplatinP J DiSaia
The Journal of Reproductive Medicine|January 1, 1975
Immunological aspects of gynecological malignanciesP J DiSaia
The Western Journal of Medicine|February 1, 1976
Tumor immunologyP J Disaia
Gynecologic Oncology|January 1, 1997
What is the proper extent of an inguinal lymphadenectomy for early vulvar cancer?P J DiSaia
Hospital Practice (Office Ed.)|April 15, 1987
Diagnosis and management of ovarian cancerP J DiSaia
Cancer|July 15, 1981
Surgical aspects of cervical carcinomaP J DiSaia
Seminars in Surgical Oncology|September 1, 1994
Gynecological sarcomasP J DiSaia, S Pecorelli
American Journal of Clinical Oncology|February 1, 1991
Human lymphoblastoid interferon (IFN-alpha-N1) plus doxorubicin, cyclophosphamide, and cisplatin in the treatment of advanced epithelial ovarian malignancies. A phase I-II study of the Gynecologic Oncology GroupP J DiSaia, P Gillette
Pageof 24